Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zsofia Kiss

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Endocrine-Related Cancer|September 24, 2016
WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancerZsofia Kiss, Paramita M Ghosh
Genes & Cancer|June 25, 2020
Non-circadian aspects of BHLHE40 cellular function in cancerZsofia Kiss, Maria Mudryj, Paramita M Ghosh
Virology|May 8, 2010
Lettuce infectious yellows virus (LIYV) RNA 1-encoded P34 is an RNA-binding protein and exhibits perinuclear localizationJinbo Wang, Lucy R Stewart, Zsofia Kiss, et al.
Cancers|January 11, 2025
Preclinical Models for Functional Precision Lung Cancer ResearchJie-Zeng Yu, Zsofia Kiss, Weijie Ma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence and Impact on Decision MakingTing-An Tai, Nicholas R Latimer, Ágnes Benedict, et al.
Plos One|September 17, 2013
Use of recombinant tobacco mosaic virus to achieve RNA interference in plants against the citrus mealybug, Planococcus citri (Hemiptera: Pseudococcidae)Arif Muhammad Khan, Muhammad Ashfaq, Zsofia Kiss, et al.
Advances in Therapy|April 21, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic DrugsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Future Oncology (London, England)|July 16, 2026
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective studyJohn Nakayama, Madeline Richey, Khilna Patel, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Future Oncology (London, England)|July 14, 2025
Real-world post-2020 first-line maintenance treatment patterns in patients with advanced ovarian cancer in the USDana M Chase, Linda Kalilani, Maureen A Cooney, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Endocrine-Related Cancer|September 24, 2016
WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancerZsofia Kiss, Paramita M Ghosh
Genes & Cancer|June 25, 2020
Non-circadian aspects of BHLHE40 cellular function in cancerZsofia Kiss, Maria Mudryj, Paramita M Ghosh
Virology|May 8, 2010
Lettuce infectious yellows virus (LIYV) RNA 1-encoded P34 is an RNA-binding protein and exhibits perinuclear localizationJinbo Wang, Lucy R Stewart, Zsofia Kiss, et al.
Cancers|January 11, 2025
Preclinical Models for Functional Precision Lung Cancer ResearchJie-Zeng Yu, Zsofia Kiss, Weijie Ma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence and Impact on Decision MakingTing-An Tai, Nicholas R Latimer, Ágnes Benedict, et al.
Plos One|September 17, 2013
Use of recombinant tobacco mosaic virus to achieve RNA interference in plants against the citrus mealybug, Planococcus citri (Hemiptera: Pseudococcidae)Arif Muhammad Khan, Muhammad Ashfaq, Zsofia Kiss, et al.
Advances in Therapy|April 21, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic DrugsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Future Oncology (London, England)|July 16, 2026
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective studyJohn Nakayama, Madeline Richey, Khilna Patel, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Future Oncology (London, England)|July 14, 2025
Real-world post-2020 first-line maintenance treatment patterns in patients with advanced ovarian cancer in the USDana M Chase, Linda Kalilani, Maureen A Cooney, et al.
Pageof 2